Craft
Viela Bio

Viela Bio

Revenue

$11.7 M

FY, 2020

Viela Bio Summary

Company summary

Overview
Viela Bio is a clinical-stage biotechnology company advancing treatments for severe inflammation and autoimmune diseases by selectively targeting shared critical pathways that are the root cause of disease.
Type
Subsidiary
Founded
2018
HQ
Gaithersburg, MD, US | view all locations
Website
https://vielabio.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Bing Yao

    Bing Yao, Chairman and Chief Executive Officer

    • Mitchell Chan

      Mitchell Chan, Chief Financial Officer

      • Edward Hu, Director

        • Yanling Cao, Director

          Operating MetricsView all

          Patents and Patent Applications

          113

          Sep, 2019

          Registration Phase Products

          1

          Sep, 2019

          Phase I Trials Products

          6

          Sep, 2019

          LocationsView all

          2 locations detected

          • Gaithersburg, MD HQ

            United States

            1 Medimmune Way

          • Rockville, MD

            United States

            2400 Research Blvd

          Viela Bio Financials

          Summary financials

          Revenue (FY, 2020)
          $11.7M
          Net income (FY, 2020)
          ($150.7M)
          Cash (FY, 2020)
          $130.1M
          EBIT (FY, 2020)
          ($153.9M)

          Footer menu